Clinical hysteria was a medical diagnosis used for centuries to describe physical symptoms, such as paralysis, seizures, and blindness, that had no apparent physical cause. The term is no longer used in medicine. It was officially dropped from the Diagnostic and Statistical Manual of Mental Disorders (DSM) in 1980, and the conditions it once described are now classified under more precise names: functional neurological symptom disorder (also called conversion disorder) in the DSM-5, and dissociative neurological symptom disorder in the international diagnostic system (ICD-11).
The shift wasn’t just a name change. It reflected a fundamentally different understanding of what causes these very real symptoms and how to treat the people experiencing them.
Why the Term Was Abandoned
The word “hysteria” comes from the Greek word for uterus, and for much of medical history the diagnosis was applied almost exclusively to women. Ancient physicians believed the uterus could wander through the body and cause symptoms. While that theory was eventually discarded, the gendered assumptions baked into the diagnosis persisted for centuries. By the late 20th century, clinicians recognized that the label was both scientifically imprecise and stigmatizing. Older terms like “psychogenic,” “hysterical,” and “nonorganic” have all fallen out of favor for similar reasons.
When the DSM-III was published in 1980, “hysterical neurosis” was deleted as a category. The symptoms it described were reclassified as manifestations of dissociative disorders and, eventually, as functional neurological symptom disorder. This reclassification placed the focus on what the symptoms actually look like and how the brain produces them, rather than on outdated ideas about emotional instability.
What These Symptoms Look Like
The conditions formerly called hysteria involve real, often disabling neurological symptoms that aren’t caused by structural damage to the nervous system. The two most common forms are functional seizures (sometimes called psychogenic nonepileptic seizures) and functional movement disorders. But the range of symptoms is broad:
- Weakness or paralysis in the arms or legs
- Seizure-like episodes that resemble epilepsy but show no abnormal electrical activity in the brain
- Abnormal movements such as tremors, jerking, or difficulty walking
- Sensory loss including numbness, blindness, or hearing disturbances
- Speech problems such as slurred speech or loss of voice
- Swallowing difficulties
These symptoms are not faked or imagined. The person genuinely cannot move their limb, see clearly, or stop shaking. The difference from conditions like multiple sclerosis or epilepsy is that the symptoms don’t match patterns of known neurological disease. A neurologist can often identify specific physical signs that are incompatible with structural nerve damage, and this incompatibility is now a core part of the diagnostic criteria.
What Happens in the Brain
Brain imaging studies have started to reveal why these symptoms occur. Functional neurological disorder appears to involve disrupted communication between several brain networks, particularly those responsible for processing emotions, directing attention, sensing the body, and controlling movement.
One area that comes up repeatedly in research is a region involved in the sense of self-agency, the feeling that you are the one controlling your own movements. In people with functional tremor, for example, this region shows reduced activity during involuntary movements compared to voluntary ones, and its connections to the areas that control movement are weakened. In practical terms, the brain is generating a movement or blocking a sensation, but the part of the brain that would normally register “I’m doing this” isn’t fully engaged. The result is a symptom that feels entirely involuntary, because at the level of brain processing, it is.
The Role of Trauma and Stress
Not everyone with functional neurological symptoms has a history of trauma, but the association is strong. In one study, 70% of patients reported childhood trauma and 64% had experienced a recent stressful life event. Roughly 80% of participants reported at least one adverse childhood experience, a rate significantly higher than the general population.
The DSM-5 diagnosis allows clinicians to specify whether a psychological stressor is present, but it no longer requires one. This is an important distinction. Earlier versions of the diagnosis implied that symptoms were always a direct conversion of emotional distress into physical form (hence the name “conversion disorder”). Current understanding is more nuanced: stress and trauma are significant risk factors, but some people develop these symptoms without any identifiable psychological trigger.
How Common It Is
These conditions are far from rare. About one in five outpatients seen in a neurology clinic has symptoms that can’t be attributed to neurological disease. Studies estimate that 20% to 25% of patients in general hospital settings have individual conversion symptoms, and about 5% meet the full diagnostic criteria. When tracked through psychiatric registries, the lifetime prevalence of the full disorder is roughly 11 to 22 per 100,000 people. Women are diagnosed more often than men, and the condition can appear at any age.
The Misdiagnosis Problem
One reason clinicians have become more careful about this diagnosis is its history of getting it wrong in both directions. In older studies, up to 30% of patients initially diagnosed with conversion disorder were later found to have an underlying neurological disease that explained their symptoms. With modern imaging tools like MRI, that rate has dropped to somewhere between 4% and 15%, but it hasn’t disappeared.
A follow-up study tracking 99 patients over 7 to 11 years found that 30% of those available for reassessment eventually received an organic neurological diagnosis. Another study found that 18% to 64% of people with conversion disorder also had a coexisting or previous neurological condition. These numbers underscore why the diagnostic process needs to involve thorough neurological evaluation rather than simply ruling out obvious diseases and defaulting to a functional label.
Treatment and Recovery
The most effective treatment currently supported by evidence combines physical rehabilitation with psychological therapy. A randomized clinical trial published in JAMA Neurology tested a program that paired 12 sessions of specialized physiotherapy with four group sessions of cognitive behavioral therapy. At five months, 58% of patients in the combined treatment group reported being “much improved” or “very much improved,” compared to just 5% in a control group that received only a standard diagnosis and nondirected psychological support. Twenty percent of previously unemployed patients in the treatment group returned to work or school; none in the control group did.
Longer-term follow-up studies of similar multidisciplinary approaches show that up to 66% of patients report sustained improvement in their symptoms over time. Treatment guidelines for functional seizures specifically recommend against prescribing anti-seizure medications, which carry side effects and show no benefit for these patients. Instead, clinicians are encouraged to clearly explain the diagnosis, taper off unnecessary medications, screen for co-occurring psychiatric conditions like depression or anxiety, and refer patients to psychological therapy when appropriate.
How the diagnosis is communicated matters enormously. Patients who feel dismissed or accused of faking tend to do worse. Current guidelines emphasize respectful communication, a clear explanation of what the diagnosis means and why it was made, and shared decision-making about the treatment plan. The shift away from the word “hysteria” is part of this broader effort: giving people a diagnosis they can understand and engage with, rather than one that implies their symptoms aren’t real.